In a filing, Charles River Laboratories International Inc revealed its Former Director WALLMAN RICHARD F acquired Company’s shares for reported $1.27 million on Jul 21 ’25. In the deal valued at $150.00 per share,8,500 shares were bought.
Then, WALLMAN RICHARD F bought 4,000 shares, generating $550,000 in total proceeds.
Before that, MASSARO GEORGE sold 140 shares. Charles River Laboratories International Inc shares valued at $19,260 were divested by the Director at a price of $137.57 per share. As a result of the transaction, MASSARO GEORGE now holds 5,575 shares, worth roughly $0.84 million.
Citigroup upgraded its Charles River Laboratories International Inc [CRL] rating to a Buy from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Redburn Atlantic’s analysts, who increased its forecast for the stock in late May from “a Neutral” to “a Buy”. TD Cowen also remained covering CRL and has increased its forecast on May 14, 2025 with a “Buy” recommendation from previously “Hold” rating. Evercore ISI revised its rating on May 08, 2025. It rated CRL as “an Outperform” which previously was an “an In-line”.
Price Performance Review of CRL
On Monday, Charles River Laboratories International Inc [NYSE:CRL] saw its stock fall -3.04% to $149.79. Over the last five days, the stock has lost -5.22%. Charles River Laboratories International Inc shares have fallen nearly -32.87% since the year began. Nevertheless, the stocks have fallen -18.86% over the past one year.
How much short interest is there in Charles River Laboratories International Inc?
A steep rise in short interest was recorded in Charles River Laboratories International Inc stocks on 2025-06-13, dropping by -0.16 million shares to a total of 2.61 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 2.76 million shares. There was a decline of -5.98%, which implies that there is a negative sentiment for the stock.
